Acquisition of a stake in the Romanian company Inocare Pharm

Horus Pharma, a leading independent French pharmaceutical company specialising in ophthalmology, today announced its first investment in a foreign company with the acquisition of a significant stake in Inocare Pharm, a Romanian company based in Bucharest. This strategic acquisition demonstrates Horus Pharma’s commitment to strengthening its international presence by partnering with established and recognised local players.

A strategic partnership for both parties

  • press-release_acquisition-of-a-stake-in-inocare-pharm_20241105.pdf
    Download